Prof Margaret Ashcroft has been awarded a Cancer Research UK (CR-UK) Bayer Healthcare co-funded drug discovery award to progress her group’s novel hypoxia signalling small molecule inhibitors towards clinical development. Prof Margaret Ashcroft will lead the multidisciplinary project partnership with Bayer, and involves her collaborations with University College London (UCL) School of Pharmacy and Cancer Research Technology (CRT).
Prof Ashcroft has also been awarded Honorary Membership of the Royal College of Radiologists (RCR) by The President and RCR Honours Committee. A limited number of individuals in the UK who have made notable contributions to clinical radiology and/or clinical oncology are honoured by the RCR. Prof Ashcroft will formally receive this honour at the Admissions of Fellows Ceremony in May 2015